Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

被引：0
|
作者：
Taryn A. G. Quinlan
Brock Schroeder
Sue Kwon
Jane F. Barlow
Michael S. Sherman
Heather D. Anderson
Garth Wright
R. Brett McQueen
机构：
[1] University of Colorado Anschutz Medical Campus,Department of Health Systems, Management and Policy
[2] Illumina,Department of Clinical Pharmacy
[3] Inc.,Department of Population Medicine
[4] University of Colorado Anschutz Medical Campus,Skaggs School of Pharmacy and Pharmaceutical Sciences
[5] Real Endpoints,undefined
[6] LLC,undefined
[7] Harvard Pilgrim Health Care,undefined
[8] Harvard Medical School,undefined
[9] University of Colorado,undefined
来源：
PharmacoEconomics - Open | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 458
页数：9
相关论文
共 50 条
  • [21] Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol
    Buela, Gabriela
    Di Giuseppe, L. A.
    Zacariaz Hereter, J. B.
    Adrian Terrasa, Sergio
    Garfi, L. A.
    Soriano, E. R.
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2022, 22
  • [22] Non-invasive prenatal testing: impact on invasive prenatal diagnosis at a mainland Chinese tertiary medical center
    Li, Dong-Zhi
    Zhen, Li
    Pan, Min
    Han, Jin
    Yang, Xin
    Ou, Yan-Mei
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (21): : 3539 - 3541
  • [23] The impact of non-invasive prenatal testing on the practice of maternal fetal medicine
    Friel, Lara
    Czerwinski, Jennifer
    Singletary, Claire
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S238 - S238
  • [24] Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing
    Gug, Miruna
    Ratiu, Adrian
    Andreescu, Nicoleta
    Farcas, Simona
    Laitin, Sorina
    Gug, Cristina
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (04):
  • [25] International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market
    Xu, Weiwei
    Wu, Jing
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (05) : 486 - 491
  • [26] AGREEMENT BETWEEN FDA APPROVED DRUG LABEL AND PERFORMANCE BASED RISK-SHARING ARRANGEMENT ENDPOINTS
    Pham, N. N.
    Carlson, J. J.
    VALUE IN HEALTH, 2018, 21 : S119 - S119
  • [27] A decade of non-invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testing
    Hui, Lisa
    Halliday, Jane
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2023, 63 (02): : 264 - 267
  • [28] ISUOG Consensus Statement on the Impact of Non-invasive Prenatal Testing (NIPT) on Prenatal Ultrasound Practice
    Salomon, L. J.
    Alfirevic, Z.
    Audibert, F.
    Kagan, K. O.
    Paladini, D.
    Yeo, G.
    Raine-Fenning, N.
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2014, 218 (06): : 242 - 243
  • [29] Budget impact of incorporating non-invasive prenatal testing in prenatal screening for Down syndrome in Turkey
    Okem, Zeynep Guldem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, Mehmet Sinan
    HEALTH POLICY AND TECHNOLOGY, 2019, 8 (04) : 402 - 407
  • [30] The psychological impact of receiving an incidental finding with Non-Invasive Prenatal Testing (NIPT)
    Bakkeren, I. M.
    Henneman, L.
    Bekker, M. N.
    van Vliet-Lachotzki, E. H.
    Galjaard, R. H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 792 - 792
12345